Oct. 8, 2009 (Business Wire) -- Carbon Sciences Inc. (OTCBB: CABN) featured in updated analyst report by Beacon Analyst, Victor Sula, Ph.D.
The full report is available at www.beaconequity.com
Anyone interested in receiving alerts regarding CABN research should e-mail members@beaconequity.com with “CABN” in the subject line.
In the report, the analyst writes, “The Company announced an important technical breakthrough that uses synthetic biology to achieve pathway for industrial scale-up of CO2 to fuel technology. … In October, the Company announced that it has invented a nano-scale reactor that functions like a highly efficient artificial microorganism that contains a proprietary enzyme process and serves a single purpose – to absorb CO2 molecules and excrete fuel molecules. This nano-scale reactor, called Smart Particle™, is the key to achieving a fast reaction time and industrial scale up of the Company’s CO2-to-Fuel process. The patent application for Smart Particle Technology contains the detailed design of Smart Particles as well as a proprietary manufacturing process where they self-assemble in solution without any external nano-manufacturing.”
Other companies in the clean technology sector include: Calgon Carbon Corp. (NYSE: CCC), Fuel Tech Inc. (Nasdaq: FTEK), Donaldson Company Inc. (NYSE: DCI) and Capstone Turbine Corp. (Nasdaq: CPST).
Beacon Equity Research Disclosure
The analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a Web site wholly owned by BlueWave Advisors, LLC, which has purchased one million shares of restricted stock from CABN at ten cents per share; additionally, BlueWave Advisors LLC and its affiliates have been previously compensated a total of sixty-thousand dollars directly from CABN as a marketing budget, which has expired, to manage a comprehensive investor awareness program including the creation and distribution of this report as well as other investor relations efforts. BlueWave Advisors also expects to receive an additional one million restricted shares directly from CABN for additional investor awareness services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Please read our report and visit our Web site, BeaconEquity.com, for complete disclosures. CRD number 2207572
